当前位置: 首页 > 详情页

Hepatotoxicity of nanomaterials: From mechanism to therapeutic strategy

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Xiamen Univ, Inst Chest & Lung Dis, Xiamen 361101, Peoples R China [2]Fujian Med Univ, Nanomed Technol Res Inst, Sch Pharm, Key Lab Nanomed Technol,Educ Dept Fujian Prov, Fuzhou 350122, Peoples R China [3]Xiamen Univ, Inst Neurosci, Med Coll, Fujian Prov Key Lab Neurodegenerat Dis & Aging Res, Xiamen 361102, Peoples R China [4]Xiamen Univ, Affiliated Hosp 1, Xiamen 361005, Peoples R China [5]Capital Med Univ, Hosp Hebei Med Univ 1, Hebei Hosp, Xuanwu Hosp, Shijiazhuang 50000, Peoples R China
出处:
ISSN:

关键词: nanomaterial hepatotoxicity liver injury

摘要:
Most nanoparticles are metabolized and accumulated in the liver; therefore, this review, based on most data collected from PubMed.gov between 2012 and 2023 with the keywords "nanomaterials induced hepatotoxicity," aims to elucidate the mechanism of nanoparticles leading to liver injury and propose relevant strategies. We discuss the biomedical approaches and strategies for mitigating liver injury, including 1) principle and recommendation of material selection; 2) nanoparticle surface modulation; 3) strategies inspired by virus and other biological phenomenon; and 4) drug and other possible adjunctive strategies. The optimal design of nanomaterials and therapeutic strategies to attenuate hepatotoxicity is critical for the development of nanomedicine.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 材料科学
小类 | 3 区 化学:综合 3 区 材料科学:综合 3 区 纳米科技 3 区 物理:应用
最新[2023]版:
大类 | 3 区 材料科学
小类 | 3 区 化学:综合 3 区 材料科学:综合 3 区 纳米科技 3 区 物理:应用
JCR分区:
出版当年[2022]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q1 PHYSICS, APPLIED Q2 NANOSCIENCE & NANOTECHNOLOGY
最新[2023]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 PHYSICS, APPLIED Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q2 NANOSCIENCE & NANOTECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [3]Xiamen Univ, Inst Neurosci, Med Coll, Fujian Prov Key Lab Neurodegenerat Dis & Aging Res, Xiamen 361102, Peoples R China [4]Xiamen Univ, Affiliated Hosp 1, Xiamen 361005, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Xiamen Univ, Inst Chest & Lung Dis, Xiamen 361101, Peoples R China [2]Fujian Med Univ, Nanomed Technol Res Inst, Sch Pharm, Key Lab Nanomed Technol,Educ Dept Fujian Prov, Fuzhou 350122, Peoples R China [3]Xiamen Univ, Inst Neurosci, Med Coll, Fujian Prov Key Lab Neurodegenerat Dis & Aging Res, Xiamen 361102, Peoples R China [4]Xiamen Univ, Affiliated Hosp 1, Xiamen 361005, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16470 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院